Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 154Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Atripla

02 4Complera/Eviplera

03 3Stribild

04 5Truvada

05 6Vemlidy

06 10Viread

PharmaCompass

01

Brand Name : Vemlidy

Tenofovir Disoproxil Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Vemlidy

arrow
Fi Europe 2024
Not Confirmed

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 657

2019 Revenue in Millions : 488

Growth (%) : 35

blank

02

Brand Name : Complera/Eviplera

Tenofovir Disoproxil Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Complera/Eviplera

arrow
Fi Europe 2024
Not Confirmed

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 269

2019 Revenue in Millions : 406

Growth (%) : -34

blank

03

Brand Name : Truvada

Tenofovir Disoproxil Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Truvada

arrow
Fi Europe 2024
Not Confirmed

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,448

2019 Revenue in Millions : 2,813

Growth (%) : -49

blank

04

Brand Name : Atripla

Tenofovir Disoproxil Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Atripla

arrow
Fi Europe 2024
Not Confirmed

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 349

2019 Revenue in Millions : 600

Growth (%) : -42

blank

05

Brand Name : Viread

Tenofovir Disoproxil Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Viread

arrow
Fi Europe 2024
Not Confirmed

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 185

2019 Revenue in Millions : 243

Growth (%) : -24

blank

06

Brand Name : Stribild

Tenofovir Disoproxil Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Stribild

arrow
Fi Europe 2024
Not Confirmed

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 196

2019 Revenue in Millions : 369

Growth (%) : -47

blank

07

Brand Name : Vemlidy

Tenofovir Disoproxil Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Vemlidy

arrow
Fi Europe 2024
Not Confirmed

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 814

2020 Revenue in Millions : 657

Growth (%) : 24

blank

08

Brand Name : Complera/Eviplera

Tenofovir Disoproxil Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Complera/Eviplera

arrow
Fi Europe 2024
Not Confirmed

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 258

2020 Revenue in Millions : 269

Growth (%) : -4

blank

09

Brand Name : Truvada

Tenofovir Disoproxil Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Truvada

arrow
Fi Europe 2024
Not Confirmed

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 371

2020 Revenue in Millions : 1,448

Growth (%) : -74

blank

10

Brand Name : Atripla

Tenofovir Disoproxil Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Atripla

arrow
Fi Europe 2024
Not Confirmed

Tenofovir Disoproxil Fumarate

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 145

2020 Revenue in Millions : 349

Growth (%) : -58

blank